Explore 25 Everyday Items That Changed The World, from the light bulb to the smartphone. Uncover the profound impact these ...

Feb 18 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

Feb 19 (Reuters) - German biopharmaceutical company BioNTech (22UAy.DE), opens new tab sued Moderna (MRNA.O), opens new tab in Delaware federal court on Thursday, alleging that Moderna's COVID-19 shot ...

Add Yahoo as a preferred source to see more of our stories on Google. A universal vaccine for cold, flu, Covid and allergies has moved a significant step closer, scientists believe. Christina ...

The past year has been a big one for Apple Wallet and CarPlay additions, and Apple has teased that more is coming. Last WWDC, the company named 13 new automakers that had pledged to add car keys in ...

Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the ...

Hughes is a partner with the law firm Epstein Becker Green and a professorial lecturer in law at the George Washington University Law School. He previously served as vice president of public policy at ...

Dr. Ralph Abraham, the agency’s principal deputy director, has called the Covid vaccines “dangerous.” Other skeptics have recently left federal health roles. By Apoorva Mandavilli Adding to a rapid ...

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. By Christina Jewett and ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

The U.S. Food and Drug Administration will review a messenger RNA (mRNA) flu vaccine for approval, according to its maker, Moderna. The decision is a dramatic U-turn for the agency, which, only about ...

Moderna said Wednesday the Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the original submission and fueling ...